Cancer BiologyHaematologicaPeer-reviewed
Metabolic vulnerabilities in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using Venetoclax
Dallas Jones, Elena Woods, Zhenhua Li…·Michael R. Verneris
This study identifies metabolic vulnerabilities in Down syndrome B-cell acute lymphoblastic leukemia and shows that Venetoclax effectively targets these vulnerabilities.
1 citation